Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Schultz

Showing results (401-410 of 413) with videos related to

Pageof 42
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 30, 2003
Genome-scale functional profiling of the mammalian AP-1 signaling pathwaySumit K Chanda, Suhaila White, Anthony P Orth, et al.
Science (New York, N.Y.)|August 22, 2020
Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimeticEmily N Chin, Chenguang Yu, Vincent F Vartabedian, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
A Large-scale Drug Repositioning Survey for SARS-CoV-2 AntiviralsLaura Riva, Shuofeng Yuan, Xin Yin, et al.
Journal of Medicinal Chemistry|February 9, 2024
Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel WarheadN G R Dayan Elshan, Karen C Wolff, Laura Riva, et al.
Journal of Medicinal Chemistry|June 14, 2024
Correction to "Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead"N G R Dayan Elshan, Karen C Wolff, Laura Riva, et al.
Nature Communications|June 4, 2021
Drug repurposing screens identify chemical entities for the development of COVID-19 interventionsMalina A Bakowski, Nathan Beutler, Karen C Wolff, et al.
Nature|July 29, 2011
Oxysterols direct immune cell migration via EBI2Sébastien Hannedouche, Juan Zhang, Tangsheng Yi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2013
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974Jun Liu, Shifeng Pan, Mindy H Hsieh, et al.
Science (New York, N.Y.)|November 19, 2011
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discoveryStephan Meister, David M Plouffe, Kelli L Kuhen, et al.
Nature|July 31, 2025
SuFEx-based antitubercular compound irreversibly inhibits Pks13Inna V Krieger, Paridhi Sukheja, Baiyuan Yang, et al.
Pageof 42

Showing results (401-410 of 413) with videos related to

Sort By:
Pageof 42
Proceedings of the National Academy of Sciences of the United States of America|September 30, 2003
Genome-scale functional profiling of the mammalian AP-1 signaling pathwaySumit K Chanda, Suhaila White, Anthony P Orth, et al.
Science (New York, N.Y.)|August 22, 2020
Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimeticEmily N Chin, Chenguang Yu, Vincent F Vartabedian, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
A Large-scale Drug Repositioning Survey for SARS-CoV-2 AntiviralsLaura Riva, Shuofeng Yuan, Xin Yin, et al.
Journal of Medicinal Chemistry|February 9, 2024
Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel WarheadN G R Dayan Elshan, Karen C Wolff, Laura Riva, et al.
Journal of Medicinal Chemistry|June 14, 2024
Correction to "Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead"N G R Dayan Elshan, Karen C Wolff, Laura Riva, et al.
Nature Communications|June 4, 2021
Drug repurposing screens identify chemical entities for the development of COVID-19 interventionsMalina A Bakowski, Nathan Beutler, Karen C Wolff, et al.
Nature|July 29, 2011
Oxysterols direct immune cell migration via EBI2Sébastien Hannedouche, Juan Zhang, Tangsheng Yi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2013
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974Jun Liu, Shifeng Pan, Mindy H Hsieh, et al.
Science (New York, N.Y.)|November 19, 2011
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discoveryStephan Meister, David M Plouffe, Kelli L Kuhen, et al.
Nature|July 31, 2025
SuFEx-based antitubercular compound irreversibly inhibits Pks13Inna V Krieger, Paridhi Sukheja, Baiyuan Yang, et al.
Pageof 42